NASDAQ · Medical - Diagnostics & Research

BLLN (BLLN) Stock

$127.98 +1.51% NASDAQ: BLLN Healthcare

Valuation

MetricValue
Price$127.98
Market Cap$5.89B
P/E Ratio174.50
P/B Ratio8.57
P/S Ratio12.22
EPS (TTM)$0.54
52-Week High$138.70
52-Week Low$61.96
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE8.71%
ROA4.46%
ROCE3.33%
Gross Margin70.40%
Operating Margin16.45%
Net Margin7.11%
Debt/Equity0.29
Current Ratio10.92

Annual Financials (USD)

Metric202320242025
Revenue$72.0M$153.0M$305.0M
Operating Profit$-69.0M$-47.0M$16.0M
Net Profit$-83.0M$-42.0M$7.0M
EPS$-1.85$-0.93$0.06
Op Margin-96.9%-30.9%5.3%

Balance Sheet (USD)

Metric202320242025
Total Assets$192.0M$302.0M$633.0M
Total Liabilities$161.0M$134.0M$153.0M
Cash$97.0M$191.0M$496.0M
Borrowings$146.0M$109.0M$109.0M

Latest News

BillionToOne Insider Sold Shares Worth $1,821,628, According to a Recent SEC Filing MT Newswires · Jul 21, 2026 BillionToOne Appoints Ethan Dmitrovsky, MD, as Chief Medical Officer, Oncology, to Lead Medical Strategy for Northstar PR Newswire · Jul 20, 2026 Billiontoone Insider Sold Shares Worth $2,497,698, According to a Recent SEC Filing MT Newswires · Jul 15, 2026 Billiontoone Insider Sold Shares Worth $533,330, According to a Recent SEC Filing MT Newswires · Jul 15, 2026 BillionToOne to Report Second Quarter 2026 Financial Results on August 5, 2026 GlobeNewswire · Jul 15, 2026

Cash Flow (USD)

Metric202320242025
Operating Cash Flow$-54.0M$-41.0M$25.0M
Investing Cash Flow$77.0M$-11.0M$-18.0M
Financing Cash Flow$0$-1.0M$0
Net Cash Flow$97.0M$94.0M$304.0M
Free Cash Flow$-60.0M$-47.0M$16.0M

Valuation & Return Ratios

MetricValue
PEG Ratio147.97
EV / EBITDA91.59
FCF Yield0.65%
Quick Ratio10.58
Interest Coverage—
Return 1Y—
Return 3Y—
Return 5Y—

Ownership

Insiders Held46.74%
Institutions Held37.38%
Institutions Float Held70.18%
Institutional HolderSharesReport Date
Adams Street Partners, LLC1,711,4302026-03-31
BAILLIE GIFFORD & CO1,259,9932026-03-31
Civilization Ventures Management, LLC1,099,4312026-03-31
BAMCO Inc.741,4852026-03-31
Price (T.Rowe) Associates Inc737,5182026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About BLLN

BLLN stock trades at $127.98 with a market capitalization of $5.89B. The stock is valued at a price-to-earnings (P/E) ratio of 174.50, price-to-book of 8.57, price-to-sales of 12.22. Over the past 52 weeks the stock has ranged between $61.96 and $138.70, and currently trades 7.7% below its 52-week high.

On profitability, BLLN generates a return on equity (ROE) of 8.71%, return on capital employed of 3.33%, an operating margin of 16.45%, a net profit margin of 7.11%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides